Search research articles
Contact Us
Filters
Showing results (41-50 of 139) with videos related to
Page
of 14
Sort By:
Pacing and Clinical Electrophysiology : PACE
|
December 10, 1999
AV conduction with atrial rate adaptive pacing in the bradycardia tachycardia syndrome
B Schwaab, G Fröhlig, C Pistorius, et al.
Herzschrittmachertherapie & Elektrophysiologie
|
June 5, 2009
[Not Available]
M Kindermann, B Schwaab, M Berg, et al.
European Journal of Clinical Pharmacology
|
January 1, 1996
Progress in the prostaglandin E1-therapy of the intermittent claudication by means of bolus injections of LIPO-prostaglandin E1 (LIPO-PGE1)
P Scheffler, J Gross, T Markwirth, et al.
Catheterization and Cardiovascular Diagnosis
|
May 1, 1997
Coronary implantation of silicone-carbide-coated Palmaz-Schatz stents in patients with high risk of stent thrombosis without oral anticoagulation
C Ozbek, A Heisel, B Gross, et al.
Pacing and Clinical Electrophysiology : PACE
|
August 26, 1999
Five-year follow-up of a bipolar steroid-eluting ventricular pacing lead
B Schwaab, G Fröhlig, M Berg, et al.
Pacing and Clinical Electrophysiology : PACE
|
January 1, 1997
Antitachycardia pacing in patients with implantable cardioverter defibrillators: how many attempts are useful?
R Fries, A Heisel, G Kalweit, et al.
The American Journal of Cardiology
|
September 12, 1996
Atrial defibrillation: can modifications in current implantable cardioverter-defibrillators achieve this?
A Heisel, J Jung, R Fries, et al.
Pacing and Clinical Electrophysiology : PACE
|
November 24, 1998
Bipolar active fixation atrial leads: comparison of two new lead models
M Kindermann, B Schwaab, G Fröhlig, et al.
Arzneimittel-Forschung
|
January 1, 1976
[Influence of a pressure agent on blood concentrations of glucose, lactate, pyruvate and free fatty acids (author's transl)]
G Rettig, N Sternitzke, H Schieffer, et al.
Cardiovascular Research
|
April 1, 1990
Optimised function for determining time to peak creatine kinase and creatine kinase-MB as non-invasive reperfusion indicators after thrombolytic therapy in acute myocardial infarction
H Schwerdt, C Ozbek, G Fröhlig, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 139) with videos related to
Sort By:
Page
of 14
Pacing and Clinical Electrophysiology : PACE
|
December 10, 1999
AV conduction with atrial rate adaptive pacing in the bradycardia tachycardia syndrome
B Schwaab, G Fröhlig, C Pistorius, et al.
Herzschrittmachertherapie & Elektrophysiologie
|
June 5, 2009
[Not Available]
M Kindermann, B Schwaab, M Berg, et al.
European Journal of Clinical Pharmacology
|
January 1, 1996
Progress in the prostaglandin E1-therapy of the intermittent claudication by means of bolus injections of LIPO-prostaglandin E1 (LIPO-PGE1)
P Scheffler, J Gross, T Markwirth, et al.
Catheterization and Cardiovascular Diagnosis
|
May 1, 1997
Coronary implantation of silicone-carbide-coated Palmaz-Schatz stents in patients with high risk of stent thrombosis without oral anticoagulation
C Ozbek, A Heisel, B Gross, et al.
Pacing and Clinical Electrophysiology : PACE
|
August 26, 1999
Five-year follow-up of a bipolar steroid-eluting ventricular pacing lead
B Schwaab, G Fröhlig, M Berg, et al.
Pacing and Clinical Electrophysiology : PACE
|
January 1, 1997
Antitachycardia pacing in patients with implantable cardioverter defibrillators: how many attempts are useful?
R Fries, A Heisel, G Kalweit, et al.
The American Journal of Cardiology
|
September 12, 1996
Atrial defibrillation: can modifications in current implantable cardioverter-defibrillators achieve this?
A Heisel, J Jung, R Fries, et al.
Pacing and Clinical Electrophysiology : PACE
|
November 24, 1998
Bipolar active fixation atrial leads: comparison of two new lead models
M Kindermann, B Schwaab, G Fröhlig, et al.
Arzneimittel-Forschung
|
January 1, 1976
[Influence of a pressure agent on blood concentrations of glucose, lactate, pyruvate and free fatty acids (author's transl)]
G Rettig, N Sternitzke, H Schieffer, et al.
Cardiovascular Research
|
April 1, 1990
Optimised function for determining time to peak creatine kinase and creatine kinase-MB as non-invasive reperfusion indicators after thrombolytic therapy in acute myocardial infarction
H Schwerdt, C Ozbek, G Fröhlig, et al.
Page
of 14